Blood Journal
Leading the way in experimental and clinical research in hematology

Distinct severity of HLH in both human and murine mutants with complete loss of cytotoxic effector PRF1, RAB27A and STX11

  1. Fernando E. Sepulveda1,
  2. Franck Debeurme2,
  3. Gaël Ménasché1,
  4. Mathieu Kurowska1,
  5. Marjorie Côte1,
  6. Jana Pachlopnik Schmid3,
  7. Alain Fischer1, and
  8. Geneviève de Saint Basile1,*
  1. 1 Institut National de la Sante et la Recherche Medical, INSERM U768, Paris, France;
  2. 2 Universite Paris Descartes-Sorbone Paris Cite, Institut Imagine, Paris, France;
  3. 3 Unite d'Immunologie et Hematologie Pediatrique, Assistance Publique-Hopitaux de Paris, Hopital Necker Enfants-Malades, Paris, France
  1. * Corresponding author; email: genevieve.de-saint-basile{at}inserm.fr

To view this item, select one of the options below

If you already have a subscription, you may gain access using your ASH username and password.

Sign In for Institutional Administrators

If you are a Librarian or institutional account administrator you can use this link to manage your account and view usage reports.

 

Purchase Short-Term Access

Pay per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00.
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.

OpenAthens Users

Log in through your institution

Sign Up

Subscribe to the Journal - Subscribe to the print and/or online journal.

Access for Patients

Access for Patients - Patients desiring access should contact the journal.